NCI SBIR/STTR Omnibus (Next Receipt 5)
Supports small businesses developing cancer technologies through national NIH collaboration pathways.
The NCI Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) Omnibus is the primary non-dilutive federal funding mechanism for US small businesses developing cancer-relevant technologies. NCI participates as a contributing Institute in the NIH-wide SBIR/STTR Omnibus administered by NIH OER/SEED. Covered mechanisms are R43 (SBIR Phase I), R44 (SBIR Phase II), R41 (S…
Cancer diagnostics, therapeutics, devices, digital health, and research tools. Any cancer-relevant innovation area.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Guides for this application
All guides →SBIR/STTR Grants for Deeptech Startups
A practical guide to SBIR and STTR grants for deeptech startups, including agency fit, Phase I and II logic, eligibility, budgets, and review criteria.
DocumentsNIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
More from NCI
All grants from this funder →Childhood, Adolescent and Young Adult (AYA) Cancer Data Innovation Challenge — Track 1
🇺🇸NCI · United States
Pays entities up to $566,665 across three milestones to add shovel-ready cancer data or tools to NCI's CCDI ecosystem.
NCI Bioengineering Research Grants (BRG)
🇺🇸NCI · United States
Supports bioengineering teams tackling cancer by connecting life and physical science groups.
Cancer Grand Challenges
🇺🇸NCI · United States
Supports large interdisciplinary global teams tackling transformative unsolved problems in cancer biology.
NCI IMAT R61 & R33
🇺🇸NCI · United States
Supports translational cancer technology from concept proof to advanced development through NCI.
NCI Small Grants Program — R03
🇺🇸NCI · United States
Supports cancer pilot research with broad domestic and international eligibility.
Similar grants
Browse the directory →
NIDDK SBIR/STTR — Next Opening
🇺🇸NIDDK · United States
Supports the United States NIDDK small business innovation pathway across metabolic, digestive, and kidney research development.
NIH SBIR Phase II (Omnibus)
🇺🇸NIH · United States
Funds United States small businesses advancing validated biomedical innovations through substantial full development execution.
NIH STTR Phase II (Omnibus)
🇺🇸NIH · United States
Funds United States small-business and research-partner teams advancing biomedical projects already proven in early studies.
NIH SBIR Fast-Track (Omnibus)
🇺🇸NIH · United States
Supports United States small businesses with streamlined biomedical pathways from feasibility to continued development.
NIH SBIR Direct-to-Phase II (Omnibus)
🇺🇸NIH · United States
Funds United States small businesses moving directly into major development when early biomedical feasibility is already established.
NIH SBIR — Receipt (First Post-Reauthorization
🇺🇸NIH · United States
Supports United States. small businesses moving vision innovation from feasibility to development.